DYAI: Rasio kapitalisasi marang pendapatan Dyadic International

The price/sales multiple for Dyadic International (DYAI) reflects the business valuation trend, with the indicator settling at 3.30. Dyadic International is optimizing laboratory supply chains, mitigating raw material shortage risks through contract diversification. Its own US-based centers utilize a fungal platform to reduce the cost of protein synthesis. This approach enables the company to compete effectively with industry behemoths by minimizing production costs.

The P/S multiple determines the market value of a business relative to its annual sales volume. This calculation allows for an assessment of the premium paid for an asset by comparing market capitalization with the actual cash flow from sales. By analyzing the capitalization-to-revenue ratio, an investor identifies points of extreme overvaluation and correction risks. For Dyadic International (DYAI), this metric remains stable, as operating expenses for biomaterial utilization are strictly regulated.